GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 105   

Articles published

GSK 52.97 +0.24 (0.46%)
price chart
Vodafone Group Plc (ADR) (VOD), GlaxoSmithKline plc (ADR) (GSK), Anheuser ...
Vodafone Group Plc (ADR) (NASDAQ:VOD) The Eurozone debt problems have held as a central focus of the financial markets since 2010.
Related articles »  
GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc ...
GlaxoSmithKline plc (ADR) Starting in reverse, Elan Corporation, plc (ADR) (NYSE:ELN) surprised investors on Monday by coming out of the bleachers and entering into a $1 billion royalty deal with Theravance Inc (NASDAQ:THRX).
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK), Merck & Co ...
Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.
Related articles »  
Merck & Co., Inc. (MRK), Illumina, Inc. (ILMN), GlaxoSmithKline plc (ADR) (GSK ...
Merck & Co., Inc. (NYSE:MRK) There's good news and bad news for Americans. The good news is that the age-adjusted death rate in the U.S.
Related articles »  
To GlaxoSmithKline, an Apology
LONDON -- Back in January, I was looking to name (and shame) the five worst stocks on the FTSE 100, when my eyes alighted on GlaxoSmithKline (LSE: GSK ) (NYSE: GSK ) . I fell on it with glee. And why not? Glaxo had been one of my most disappointing ...
Related articles »  
News Recap: NII Holdings, Companhia Siderurgica Nacional, JDS Uniphase ...
GlaxoSmithKline plc (ADR)(NYSE:GSK) shares declined 1.47% to $51.65. The company reported on April 22, that they have submitted a regulatory petition to the Japanese Ministry of Health, Labour and Welfare, or MHLW, for the investigational once-daily ...
Related articles »  
This Metric Says You Are Smart to Buy Sanofi SA (ADR) (SNY)
Let's go over hedge fund and insider activity in other stocks similar to Sanofi SA (ADR) (NYSE:SNY). These stocks are Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Novartis AG (ADR) (NYSE:NVS), GlaxoSmithKline plc (ADR) (NYSE:GSK), and ...
This Metric Says You Are Smart to Sell Bristol Myers Squibb Co. (BMY)
These stocks are Merck & Co., Inc. (NYSE:MRK), GlaxoSmithKline plc (ADR) (NYSE:GSK), AstraZeneca plc (ADR) (NYSE:AZN), Eli Lilly & Co.
Related articles »  
Hedge Funds Are Dumping Merck & Co., Inc. (MRK)
These stocks are Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Novartis AG (ADR) (NYSE:NVS), GlaxoSmithKline plc (ADR) (NYSE:GSK), and Sanofi SA (ADR) (NYSE:SNY). This group of stocks are in the drug manufacturers - major industry and ...
Johnson & Johnson (JNJ): Are Hedge Funds Right About This Stock?
These stocks are GlaxoSmithKline plc (ADR) (NYSE:GSK), Merck & Co., Inc. (NYSE:MRK), Sanofi SA (ADR) (NYSE:SNY), Novartis AG (ADR) (NYSE:NVS), and Pfizer Inc. (NYSE:PFE).
Related articles »